首頁 > 市場調查報告書 > 醫療設備

生技設備細胞培養

市場調查報告書

商品編碼

1784318

全球細胞培養市場（按產品、應用和最終用戶分類）預測（至 2030 年）

Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels ), Equipment ), Application, End User - Global Forecast to 2030

出版日期: 2025年07月31日 | 出版商:

MarketsandMarkets | 英文 765 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球細胞培養市場預計將從 2025 年的 297.6 億美元成長到 2030 年的 506.9 億美元，2025-2030 年預測期間的複合年成長率為 11.2%。

調查範圍
調查年份	2024-2030
基準年	2024
預測期	2025-2030
單元	10億美元
部分	產品、應用程式和最終用戶
目標區域	北美、歐洲、亞太地區、拉丁美洲、中東和非洲

這一市場成長可歸因於細胞生物學領域研究投入和資金的不斷增加。癌症等慢性疾病的日益流行，推動了對組織工程和再生醫學等先進治療方法的需求。預計這一趨勢將在未來幾年推動細胞培養市場的成長。

按應用分類，生物製藥生產領域在 2024 年佔據最大佔有率。

感染疾病的爆發推動了對疫苗、單株抗體和治療性蛋白質等生物製藥的需求，從而推動了細胞培養市場生物製藥產量的成長。

2024 年，血清、培養基和試劑部分佔據消耗品市場的大部分佔有率。

該細分市場的巨大佔有率源於生物技術和製藥行業對耗材的頻繁大宗購買和需求。實驗室和生產設施通常需要大量的血清、培養基、試劑、培養皿和配件來維持細胞培養的持續進行。這需要為實驗、測試和生產流程進行頻繁且大量的採購。

2024年美國將主導細胞培養市場。

2024年，美國主導北美細胞培養市場。作為全球最大的生物製藥市場，美國因其對生物製藥研究和投資的重視而佔據顯著地位。此外，美國擁有哈佛大學、史丹佛大學和麻省理工學院（MIT）等知名學術研究機構，這些機構以在藥物研發和生物技術等生命科學領域開展開創性研究而聞名，並透過廣泛應用細胞培養技術推動市場擴張。此外，美國在組織工程和再生醫學研發方面的投資不斷增加，也促進了細胞培養市場的成長。

本報告研究了全球細胞培養市場，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢的資訊。

介紹
市場動態
- 驅動程式
- 抑制因素
- 機會
- 任務
影響客戶業務的趨勢/中斷
定價分析
- 主要企業平均銷售價格趨勢：依產品分類
- 各地區產品平均售價
價值鏈分析
生態系分析
投資金籌措場景
技術分析
- 主要技術
- 互補技術
- 鄰近技術
專利分析
貿易分析
- 導入數據
- 匯出數據
大型會議和活動（2025-2026年）
關稅和監管格局
- 細胞培養產品關稅
- 法規結構
- 監管機構、政府機構和其他組織
波特五力分析
主要相關利益者和採購標準
人工智慧/生成式人工智慧對細胞培養產品市場的影響
- 介紹
- 人工智慧在細胞培養應用的市場潛力
- 人工智慧用例
- 採用人工智慧的主要企業
- 細胞培養生態系中生成式人工智慧的未來
2025年美國關稅對細胞培養市場的影響
- 介紹
- 主要關稅稅率
- 價格影響分析
- 對國家的影響
- 對終端產業的影響

第6章細胞培養市場：依產品

介紹
耗材
- 血清、培養基和試劑
- 容器
- 配件
裝置
- 生物反應器
- 倉儲設備
- 其他設備

第7章細胞培養市場：依應用

介紹
生物製藥生產
- 單株抗體生產
- 疫苗生產
- 其他治療性蛋白質的生產
診斷
組織工程與再生醫學
- 細胞和基因治療
- 其他組織工程及再生醫學應用
藥物篩檢與開發
其他用途

第 8 章細胞培養市場（依最終用戶分類）

介紹
製藥和生物技術公司
醫院和診斷實驗室
研究和學術機構
其他最終用戶

第9章細胞培養市場：按地區

介紹
北美洲
- 北美宏觀經濟展望
- 美國
- 加拿大
歐洲
- 歐洲宏觀經濟展望
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家
亞太地區
- 亞太宏觀經濟展望
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 其他亞太地區
拉丁美洲
- 拉丁美洲宏觀經濟展望
- 巴西
- 墨西哥
- 其他拉丁美洲
中東
- 中東宏觀經濟展望
- 海灣合作理事會國家
- 其他中東地區
非洲

第10章競爭格局

概述
主要參與企業的策略/優勢
收益分析（2020-2024）
市場佔有率分析（2024年）
公司估值及財務指標
品牌/產品比較
企業評估矩陣：主要企業（2024年）
公司評估矩陣：Start-Ups/中小企業（2024 年）
競爭場景

第11章：公司簡介

介紹
主要企業
- THERMO FISHER SCIENTIFIC INC.
- DANAHER
- MERCK KGAA
- SARTORIUS AG
- CORNING INCORPORATED
- FUJIFILM HOLDINGS CORPORATION
- BD
- EPPENDORF SE
- LONZA
- GETINGE
- AGILENT TECHNOLOGIES, INC.
- HIMEDIA LABORATORIES
- BIO-TECHNE
其他公司
- MILTENYI BIOTEC
- STEMCELL TECHNOLOGIES
- SOLIDA BIOTECH GMBH
- CAISSON LABS
- PROMOCELL GMBH
- INVIVOGEN
- PAN-BIOTECH
- CELLEXUS
- MEISSNER FILTRATION PRODUCTS, INC.
- ADOLF KUHNER AG
- ADVANCION CORPORATION
- BIOSPHERIX LLC

第12章附錄

簡介目錄圖表

Product Code: BT 2561

The cell culture market is projected to reach USD 50.69 billion by 2030 from an estimated USD 29.76 billion in 2025, at a CAGR of 11.2% during the forecast period of 2025 to 2030.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Product, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

The growth of this market can be attributed to growing investments and funding for research in the field of cell biology. The rising incidence of chronic diseases such as cancer is boosting the demand for advanced therapies such as tissue engineering and regenerative medicine. This trend is expected to drive the growth of the cell culture market in the coming years.

The biopharmaceutical production segment accounted for the largest share of the application segment in 2024.

In 2024, the biopharmaceutical production segment accounted for the largest share of the application segment in the global cell culture market. The biopharmaceutical production segment is further categorized into vaccine production, monoclonal antibody production, and other therapeutic protein production. The growing prevalence of infectious diseases is boosting the demand for biopharmaceuticals such as vaccines, monoclonal antibodies, and therapeutic proteins, which is promoting the growth of biopharmaceutical production in the cell culture market.

The sera, media, and reagents segment accounted for a major share of the consumables market in 2024.

The cell culture consumables market is categorized by type into sera, media, and reagents; vessels; and accessories. The sera, media, and reagents segment accounted for the largest share of the cell culture consumables market in 2024. The large share of this segment is attributed to the repeated bulk purchase and requirement for consumables in the biotechnology and pharmaceutical industries. Research labs and production facilities often require large quantities of sera, media, reagents, vessels, and accessories to sustain continuous cell culture activities. This leads to frequent and substantial procurement for experimentation, testing, and manufacturing processes.

The US dominated the cell culture market in 2024.

In 2024, the cell culture market in North America was led by the US. As the world's largest biopharmaceutical market with a strong emphasis on research and investment in biopharmaceuticals, the US holds a prominent position. Moreover, the country hosts renowned academic research institutions such as Harvard University, Stanford University, and the Massachusetts Institute of Technology (MIT), renowned for their groundbreaking work in life sciences, including drug discovery and biotechnology, which extensively employ cell culture techniques, thereby fueling market expansion. Furthermore, increasing investments in tissue engineering and regenerative medicine R&D are contributing to the growth of the cell culture market.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45%, CXOs & Directors - 30%, and Executives - 25%
By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Thermo Fisher Scientific Inc. (US)
Danaher Corporation (US)
Sartorius AG (Germany)
Merck KGaA (Germany)
Corning Incorporated (US)
FUJIFILM Holdings Corporation (Japan)
BD (US)
Eppendorf SE (Germany)
Lonza (Switzerland)
Getinge AB (Sweden)
Agilent Technologies, Inc. (US)
HiMedia Laboratories (India)
Miltenyi Biotec (Germany)
STEMCELL Technologies (Canada)
Solida Biotech GmbH (Germany)
Caisson Labs (US)
PromoCell GmbH (Germany)
InvivoGen (France)
PAN-Biotech (Germany)
Cellexus (Scotland)
Meissner Filtration Products Inc. (US)
Adolf Kuhner AG (Switzerland)
Bio-Techne (US)
Advancion Corporation (US)
BioSpherix, Ltd. (US)

Research Coverage

This research report categorizes the cell culture market by product ((equipment (bioreactors, storage equipment, and other equipment), consumables (sera, media, reagents; vessels, and accessories)), by application (biopharmaceutical production (vaccine production, monoclonal antibody production, and other therapeutic protein production), diagnostics, tissue engineering & regenerative medicine (cell & gene therapy and other tissue engineering & regenerative medicine applications), drug screening & development, and other applications), by end user (pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell culture market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are the recent developments associated with the cell culture market.

Key Benefits of Buying the Report

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (increasing prevalence of infectious diseases, rising adoption of single-use technologies, and growing strategic alliances for the development of advanced therapy medicine products), restraints (high cost of cell biology research and limitations regarding production of high density cell culture), opportunities (growing opportunities in emerging economies, rising demand for 3D cell culture), and challenges (ethical concern regarding cell usage) influencing the growth of the market.
Product Development/Innovation: Detailed insights on newly launched products of the cell culture market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell culture market
Competitive Assessment: Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US), Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kuhner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US)

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS SEGMENTATION AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 GLOBAL MARKET SIZE ESTIMATION, 2024
  - 2.2.1.1 Insights from primary sources
- 2.2.2 SEGMENTAL MARKET ESTIMATION
2.3 GROWTH RATE PROJECTIONS
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN CELL CULTURE MARKET
4.2 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT AND COUNTRY
4.3 CELL CULTURE MARKET SHARE, BY APPLICATION
4.4 CELL CULTURE MARKET SHARE, BY END USER
4.5 CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing support and funding for cell-based research
  - 5.2.1.2 Emerging cell culture technologies
  - 5.2.1.3 Growing popularity of monoclonal antibodies and biosimilars
  - 5.2.1.4 Increasing adoption of single-use technologies
  - 5.2.1.5 Rise in product launches
  - 5.2.1.6 Growth in advanced therapy medicinal products
  - 5.2.1.7 Increasing incidence of infectious diseases
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost of cell biology research
  - 5.2.2.2 Limitations in producing high-density cell cultures
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Rising demand for 3D cell culture
  - 5.2.3.2 Growth opportunities in emerging economies
  - 5.2.3.3 Increasing focus on next-generation therapeutics
- 5.2.4 CHALLENGES
  - 5.2.4.1 Disposal of plastic consumables
  - 5.2.4.2 Ethical concerns related to cell usage
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
- 5.4.2 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 INVESTMENT AND FUNDING SCENARIO
5.8 TECHNOLOGY ANALYSIS
- 5.8.1 KEY TECHNOLOGIES
  - 5.8.1.1 Single-use technology
  - 5.8.1.2 Flow cytometry
  - 5.8.1.3 Microscopy
- 5.8.2 COMPLEMENTARY TECHNOLOGIES
  - 5.8.2.1 High-throughput screening
  - 5.8.2.2 Mass spectrometry
- 5.8.3 ADJACENT TECHNOLOGIES
  - 5.8.3.1 Microfluidics and organ-on-a-chip
  - 5.8.3.2 3D bioprinting
5.9 PATENT ANALYSIS
5.10 TRADE ANALYSIS
- 5.10.1 IMPORT DATA
- 5.10.2 EXPORT DATA
5.11 KEY CONFERENCES AND EVENTS, 2025-2026
5.12 TARIFF AND REGULATORY LANDSCAPE
- 5.12.1 TARIFF RELATED TO CELL CULTURE PRODUCTS
- 5.12.2 REGULATORY FRAMEWORK
  - 5.12.2.1 North America
  - 5.12.2.2 Europe
  - 5.12.2.3 Asia Pacific
  - 5.12.2.4 Latin America
  - 5.12.2.5 Middle East & Africa
- 5.12.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 PORTER'S FIVE FORCES ANALYSIS
- 5.13.1 BARGAINING POWER OF SUPPLIERS
- 5.13.2 BARGAINING POWER OF BUYERS
- 5.13.3 THREAT OF NEW ENTRANTS
- 5.13.4 THREAT OF SUBSTITUTES
- 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.14.2 KEY BUYING CRITERIA
5.15 IMPACT OF AI/GENERATIVE AI ON CELL CULTURE PRODUCTS MARKET
- 5.15.1 INTRODUCTION
- 5.15.2 MARKET POTENTIAL OF AI IN CELL CULTURE APPLICATIONS
- 5.15.3 AI USE CASES
- 5.15.4 KEY COMPANIES IMPLEMENTING AI
- 5.15.5 FUTURE OF GENERATIVE AI IN CELL CULTURE ECOSYSTEM
5.16 IMPACT OF 2025 US TARIFF ON CELL CULTURE MARKET
- 5.16.1 INTRODUCTION
- 5.16.2 KEY TARIFF RATES
- 5.16.3 PRICE IMPACT ANALYSIS
- 5.16.4 IMPACT ON COUNTRY/REGION
  - 5.16.4.1 US
  - 5.16.4.2 Europe
  - 5.16.4.3 Asia Pacific
- 5.16.5 IMPACT ON END-USE INDUSTRIES
  - 5.16.5.1 Pharmaceutical & biotech companies
  - 5.16.5.2 Hospitals & diagnostic laboratories
  - 5.16.5.3 Academic & research institutes
  - 5.16.5.4 Contract research organizations & contract development and manufacturing organizations

6 CELL CULTURE MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 CONSUMABLES
- 6.2.1 SERA, MEDIA, AND REAGENTS
  - 6.2.1.1 Media
    - 6.2.1.1.1 Serum-free media
      - 6.2.1.1.1.1 Enhanced control, reproducibility, and decreased batch-to-batch variability to aid growth
    - 6.2.1.1.2 Classical media & salts
      - 6.2.1.1.2.1 Need for efficient and scalable vaccine production to bolster growth
    - 6.2.1.1.3 Stem cell culture media
      - 6.2.1.1.3.1 Rising funding and support for stem cell-based research and therapy to augment growth
    - 6.2.1.1.4 Chemically-defined media
      - 6.2.1.1.4.1 Rising need for reproducibility, regulatory compliance, and precise control in cell culture systems to aid growth
    - 6.2.1.1.5 Specialty media
      - 6.2.1.1.5.1 Suitability for use in selective cell types in bioprocessing and biomanufacturing industries to boost market
    - 6.2.1.1.6 Other media
  - 6.2.1.2 Reagents
    - 6.2.1.2.1 Growth factors
      - 6.2.1.2.1.1 Need to regulate cell proliferation, differentiation, and migration to sustain growth
    - 6.2.1.2.2 Supplements
      - 6.2.1.2.2.1 Growing acquisitions and expansions by cell culture vendors to propel market
    - 6.2.1.2.3 Buffers & chemicals
      - 6.2.1.2.3.1 Ability to maintain stable pH levels to facilitate growth
    - 6.2.1.2.4 Cell dissociation reagents
      - 6.2.1.2.4.1 Ability to minimize cell stress and reduce cell damage to foster growth
    - 6.2.1.2.5 Balanced salt solutions
      - 6.2.1.2.5.1 Ability to maintain optimal physiological conditions for cell growth and experimentation to assist growth
    - 6.2.1.2.6 Attachment & matrix factors
      - 6.2.1.2.6.1 Rising adoption of 3D cell culture models to support growth
    - 6.2.1.2.7 Antibiotics/Antimycotics
      - 6.2.1.2.7.1 Ability to mitigate growth of contaminating bacteria, fungi, and mycoplasma to drive market
    - 6.2.1.2.8 Cryoprotective reagents
      - 6.2.1.2.8.1 Ability to preserve cell viability during freezing and thawing to aid growth
    - 6.2.1.2.9 Contamination detection kits
      - 6.2.1.2.9.1 Need for rapid identification of microbial contaminants to promote growth
    - 6.2.1.2.10 Other reagents
  - 6.2.1.3 Sera
    - 6.2.1.3.1 Fetal bovine sera
      - 6.2.1.3.1.1 Increasing role of fetal bovine sera in cell proliferation to favor growth
    - 6.2.1.3.2 Adult bovine sera
      - 6.2.1.3.2.1 Cost-effectiveness to contribute to growth
    - 6.2.1.3.3 Other animal sera
- 6.2.2 VESSELS
  - 6.2.2.1 Cell factory systems/cell stacks
    - 6.2.2.1.1 Efficient and scalable solutions for large-scale expansion to drive adoption
  - 6.2.2.2 Roller/roux bottles
    - 6.2.2.2.1 Scalability, cost-effectiveness, and ease of handling to support growth
  - 6.2.2.3 Flasks
    - 6.2.2.3.1 Growing advancements in cell culture flasks to boost market
  - 6.2.2.4 Multiwell plates
    - 6.2.2.4.1 Increasing adoption of multiwell plates in high-throughput or high-content screening to aid growth
  - 6.2.2.5 Petri dishes
    - 6.2.2.5.1 Rising use of petri dishes as sterile containers to sustain growth
- 6.2.3 ACCESSORIES
  - 6.2.3.1 Reduced preparation time and equipment performance improvements to augment growth
6.3 EQUIPMENT
- 6.3.1 BIOREACTORS
  - 6.3.1.1 Conventional bioreactors
    - 6.3.1.1.1 Utilization in large-scale manufacturing of drugs to drive market
  - 6.3.1.2 Single-use bioreactors
    - 6.3.1.2.1 Lower operational costs and increased flexibility to boost market
- 6.3.2 STORAGE EQUIPMENT
  - 6.3.2.1 Refrigerators & freezers
    - 6.3.2.1.1 Increasing need for storage solutions to propel market
  - 6.3.2.2 Cryostorage systems
    - 6.3.2.2.1 Benefits of long-term preservation of cell cultures to support growth
- 6.3.3 OTHER EQUIPMENT
  - 6.3.3.1 Filtration systems
    - 6.3.3.1.1 Growing use in bioprocessing industry to boost market
  - 6.3.3.2 Cell counters
    - 6.3.3.2.1 Growing adoption of automated cell counters to propel market
  - 6.3.3.3 Carbon dioxide incubators
    - 6.3.3.3.1 Increasing focus of research institutes on developing lab-scale incubators to drive market
  - 6.3.3.4 Centrifuges
    - 6.3.3.4.1 Increasing demand for bioproduction applications to drive adoption of centrifuges
  - 6.3.3.5 Autoclaves
    - 6.3.3.5.1 Reliance on single-use labware and equipment to affect demand for autoclaves
  - 6.3.3.6 Microscopes
    - 6.3.3.6.1 Enhanced imaging capabilities to augment growth
  - 6.3.3.7 Biosafety cabinets
    - 6.3.3.7.1 Increasing launches of biosafety cabinets to promote growth
  - 6.3.3.8 Other supporting equipment

7 CELL CULTURE MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 BIOPHARMACEUTICAL PRODUCTION
- 7.2.1 MONOCLONAL ANTIBODY PRODUCTION
  - 7.2.1.1 Increasing approval and launch of mAb candidates to amplify growth
- 7.2.2 VACCINE PRODUCTION
  - 7.2.2.1 Rising incidence of infectious diseases to support growth
- 7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
7.3 DIAGNOSTICS
- 7.3.1 GROWING ADVANCEMENTS AND ADOPTION OF NEW TECHNIQUES TO FUEL MARKET
7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
- 7.4.1 CELL & GENE THERAPY
  - 7.4.1.1 Rising investments in developing cell-based immunotherapies to foster growth
- 7.4.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
7.5 DRUG SCREENING & DEVELOPMENT
- 7.5.1 INCREASING FOCUS ON BIOLOGIC DRUGS TO FAVOR GROWTH
7.6 OTHER APPLICATIONS

8 CELL CULTURE MARKET, BY END USER

8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 8.2.1 INCREASING DEMAND FOR CULTURE CELL LINES FOR DRUG SCREENING AND R&D TO AID GROWTH
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
- 8.3.1 GROWING USE OF CELL CULTURE FOR CELLULAR PHYSIOLOGY, DISEASE MECHANISMS, AND DRUG RESPONSES TO BOOST MARKET
8.4 RESEARCH & ACADEMIC INSTITUTES
- 8.4.1 RISING FUNDING ACTIVITIES TO CONTRIBUTE TO GROWTH
8.5 OTHER END USERS

9 CELL CULTURE MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
- 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 9.2.2 US
  - 9.2.2.1 Advanced healthcare infrastructure and government support to bolster growth
- 9.2.3 CANADA
  - 9.2.3.1 Increasing funding and investments for cell-based therapies to boost market
9.3 EUROPE
- 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 9.3.2 GERMANY
  - 9.3.2.1 Rising R&D investments and strategic alliances to promote growth
- 9.3.3 UK
  - 9.3.3.1 Growth in life science industry and favorable government investments to drive market
- 9.3.4 FRANCE
  - 9.3.4.1 Rising number of cell-based research projects to enhance growth
- 9.3.5 ITALY
  - 9.3.5.1 Strong government support for R&D activities to spur growth
- 9.3.6 SPAIN
  - 9.3.6.1 Booming biotechnology industry to bolster growth
- 9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
- 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 9.4.2 CHINA
  - 9.4.2.1 Rising focus on stem cell & regenerative medicine research to expedite growth
- 9.4.3 JAPAN
  - 9.4.3.1 Rising government initiatives and increasing investments in biotech to intensify growth
- 9.4.4 INDIA
  - 9.4.4.1 Favorable government support and expansion by key cell culture players to augment growth
- 9.4.5 SOUTH KOREA
  - 9.4.5.1 Growing pharmaceutical sector to drive market
- 9.4.6 AUSTRALIA
  - 9.4.6.1 Increasing prevalence of chronic diseases to accelerate growth
- 9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
- 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 9.5.2 BRAZIL
  - 9.5.2.1 Rising prevalence of cancer and related research activities to support growth
- 9.5.3 MEXICO
  - 9.5.3.1 Increasing advancements in biotechnology industry to spur growth
- 9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST
- 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
- 9.6.2 GCC COUNTRIES
  - 9.6.2.1 Saudi Arabia
    - 9.6.2.1.1 Increasing focus of key players on expansion to drive market
  - 9.6.2.2 UAE
    - 9.6.2.2.1 Increasing shift from importing to manufacturing pharmaceuticals to boost market
  - 9.6.2.3 Rest of GCC Countries
- 9.6.3 REST OF MIDDLE EAST
9.7 AFRICA
- 9.7.1 RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FOSTER GROWTH
- 9.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL CULTURE MARKET
10.3 REVENUE ANALYSIS, 2020-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY VALUATION AND FINANCIAL METRICS
10.6 BRAND/PRODUCT COMPARISON
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 10.7.1 STARS
- 10.7.2 EMERGING LEADERS
- 10.7.3 PERVASIVE PLAYERS
- 10.7.4 PARTICIPANTS
- 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 10.7.5.1 Company footprint
  - 10.7.5.2 Region footprint
  - 10.7.5.3 Product footprint
  - 10.7.5.4 Application footprint
  - 10.7.5.5 End-user footprint
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 10.8.1 PROGRESSIVE COMPANIES
- 10.8.2 RESPONSIVE COMPANIES
- 10.8.3 DYNAMIC COMPANIES
- 10.8.4 STARTING BLOCKS
- 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 10.8.5.1 Detailed list of key startups/SMEs
  - 10.8.5.2 Competitive benchmarking of key startups/SMEs
10.9 COMPETITIVE SCENARIO
- 10.9.1 PRODUCT LAUNCHES
- 10.9.2 DEALS
- 10.9.3 EXPANSIONS

11 COMPANY PROFILES

11.1 INTRODUCTION
11.2 KEY PLAYERS
- 11.2.1 THERMO FISHER SCIENTIFIC INC.
  - 11.2.1.1 Business overview
  - 11.2.1.2 Products offered
  - 11.2.1.3 Recent developments
    - 11.2.1.3.1 Product launches
    - 11.2.1.3.2 Deals
    - 11.2.1.3.3 Expansions
  - 11.2.1.4 MnM view
    - 11.2.1.4.1 Key strengths
    - 11.2.1.4.2 Strategic choices
    - 11.2.1.4.3 Weaknesses and competitive threats
- 11.2.2 DANAHER
  - 11.2.2.1 Business overview
  - 11.2.2.2 Products offered
  - 11.2.2.3 Recent developments
    - 11.2.2.3.1 Product launches
    - 11.2.2.3.2 Deals
    - 11.2.2.3.3 Expansions
    - 11.2.2.3.4 Other developments
  - 11.2.2.4 MnM view
    - 11.2.2.4.1 Key strengths
    - 11.2.2.4.2 Strategic choices
    - 11.2.2.4.3 Weaknesses and competitive threats
- 11.2.3 MERCK KGAA
  - 11.2.3.1 Business overview
  - 11.2.3.2 Products offered
  - 11.2.3.3 Recent developments
    - 11.2.3.3.1 Product launches
    - 11.2.3.3.2 Deals
    - 11.2.3.3.3 Expansions
  - 11.2.3.4 MnM view
    - 11.2.3.4.1 Key strengths
    - 11.2.3.4.2 Strategic choices
    - 11.2.3.4.3 Weaknesses and competitive threats
- 11.2.4 SARTORIUS AG
  - 11.2.4.1 Business overview
  - 11.2.4.2 Products offered
  - 11.2.4.3 Recent developments
    - 11.2.4.3.1 Product launches
    - 11.2.4.3.2 Deals
    - 11.2.4.3.3 Expansions
- 11.2.5 CORNING INCORPORATED
  - 11.2.5.1 Business overview
  - 11.2.5.2 Products offered
  - 11.2.5.3 Recent developments
    - 11.2.5.3.1 Product launches
    - 11.2.5.3.2 Deals
- 11.2.6 FUJIFILM HOLDINGS CORPORATION
  - 11.2.6.1 Business overview
  - 11.2.6.2 Products offered
  - 11.2.6.3 Recent developments
    - 11.2.6.3.1 Product launches
    - 11.2.6.3.2 Deals
    - 11.2.6.3.3 Expansions
    - 11.2.6.3.4 Other developments
- 11.2.7 BD
  - 11.2.7.1 Business overview
  - 11.2.7.2 Product offered
  - 11.2.7.3 Recent developments
    - 11.2.7.3.1 Product Launches
    - 11.2.7.3.2 Deals
- 11.2.8 EPPENDORF SE
  - 11.2.8.1 Business overview
  - 11.2.8.2 Products offered
  - 11.2.8.3 Recent developments
    - 11.2.8.3.1 Product launches
    - 11.2.8.3.2 Deals
    - 11.2.8.3.3 Expansions
- 11.2.9 LONZA
  - 11.2.9.1 Business overview
  - 11.2.9.2 Products offered
  - 11.2.9.3 Recent developments
    - 11.2.9.3.1 Product launches
    - 11.2.9.3.2 Deals
- 11.2.10 GETINGE
  - 11.2.10.1 Business overview
  - 11.2.10.2 Products offered
  - 11.2.10.3 Recent developments
    - 11.2.10.3.1 Product launches
    - 11.2.10.3.2 Deals
    - 11.2.10.3.3 Expansions
- 11.2.11 AGILENT TECHNOLOGIES, INC.
  - 11.2.11.1 Business overview
  - 11.2.11.2 Products offered
  - 11.2.11.3 Recent developments
    - 11.2.11.3.1 Product launches
    - 11.2.11.3.2 Deals
    - 11.2.11.3.3 Expansions
- 11.2.12 HIMEDIA LABORATORIES
  - 11.2.12.1 Business overview
  - 11.2.12.2 Products offered
- 11.2.13 BIO-TECHNE
  - 11.2.13.1 Business overview
  - 11.2.13.2 Products offered
  - 11.2.13.3 Recent developments
    - 11.2.13.3.1 Product launches
    - 11.2.13.3.2 Deals
    - 11.2.13.3.3 Expansions
11.3 OTHER PLAYERS
- 11.3.1 MILTENYI BIOTEC
- 11.3.2 STEMCELL TECHNOLOGIES
- 11.3.3 SOLIDA BIOTECH GMBH
- 11.3.4 CAISSON LABS
- 11.3.5 PROMOCELL GMBH
- 11.3.6 INVIVOGEN
- 11.3.7 PAN-BIOTECH
- 11.3.8 CELLEXUS
- 11.3.9 MEISSNER FILTRATION PRODUCTS, INC.
- 11.3.10 ADOLF KUHNER AG
- 11.3.11 ADVANCION CORPORATION
- 11.3.12 BIOSPHERIX LLC

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

簡介目錄圖表

List of Tables

TABLE 1 CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 3 CELL CULTURE MARKET: RISK ANALYSIS
TABLE 4 CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 5 NATIONAL INSTITUTES OF HEALTH FUNDING FOR STEM CELL-BASED RESEARCH, 2020-2024 (USD MILLION)
TABLE 6 FUNDING INVESTMENTS IN CELL & GENE THERAPY, 2023 - 2025
TABLE 7 COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2024
TABLE 8 ASIA PACIFIC: PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2023-2025
TABLE 9 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022-2024
TABLE 11 AVERAGE SELLING PRICE OF SINGLE-USE ASSEMBLIES, BY REGION, 2024
TABLE 12 AVERAGE SELLING PRICE OF MEDIA, BY DEVELOPING VS. DEVELOPED COUNTRIES, 2024
TABLE 13 CELL CULTURE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 14 ADVANTAGES OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS
TABLE 15 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
TABLE 16 CELL CULTURE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2025
TABLE 17 IMPORT DATA FOR HS CODE 382100, 2020-2024 (USD THOUSAND)
TABLE 18 IMPORT DATA FOR HS CODE 382100, 2020-2024 (TONS)
TABLE 19 EXPORT DATA FOR HS CODE 382100, 2020-2024 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR HS CODE 382100, 2020-2024 (TONS)
TABLE 21 CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
TABLE 22 AVERAGE TARIFF RELATED TO CELL CULTURE PRODUCTS FOR HS CODE 382100, 2024
TABLE 23 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 CELL CULTURE MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 28 BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER
TABLE 29 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 30 CELL CULTURE PRODUCTS-RELATED TARIFF REVISION
TABLE 31 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS
TABLE 32 CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 33 CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 34 CELL CULTURE CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 35 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 36 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 38 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 39 MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 40 GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 41 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 42 CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 43 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 44 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 47 MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 48 GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 49 CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 50 CELL CULTURE MEDIA MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 51 CELL CULTURE MEDIA MARKET, BY REGION, 2023-2030 (MILLION LITERS)
TABLE 52 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 53 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 55 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 56 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 57 GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 58 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 59 CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 60 NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 61 EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 62 ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 63 LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 64 MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 65 GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 66 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
TABLE 67 CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 68 NORTH AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 69 EUROPE: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 70 ASIA PACIFIC: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 71 LATIN AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 72 MIDDLE EAST: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 73 GCC COUNTRIES: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 74 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 75 CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 76 NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 77 EUROPE: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 78 ASIA PACIFIC: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 79 LATIN AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 80 MIDDLE EAST: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 81 GCC COUNTRIES: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 82 CHEMICALLY-DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 83 CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 84 NORTH AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 85 EUROPE: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 86 ASIA PACIFIC: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 87 LATIN AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 88 MIDDLE EAST: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 89 GCC COUNTRIES: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 90 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 91 CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 92 NORTH AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 93 EUROPE: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 94 ASIA PACIFIC: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 95 LATIN AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 96 MIDDLE EAST: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 97 GCC COUNTRIES: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 98 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 99 CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 100 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 101 EUROPE: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 102 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 103 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 104 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2023-2030 (USD MILLION)
TABLE 105 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 106 CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 107 CELL CULTURE REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 108 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 109 EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 110 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 111 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 112 MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 113 GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 114 CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 115 NORTH AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 116 EUROPE: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 117 ASIA PACIFIC: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 118 LATIN AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 119 MIDDLE EAST: CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 120 GCC COUNTRIES: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 121 CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 122 NORTH AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 123 EUROPE: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 124 ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 125 LATIN AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 126 MIDDLE EAST: CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 127 GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 128 CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2023-2030 (USD MILLION)
TABLE 129 NORTH AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 130 EUROPE: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 131 ASIA PACIFIC: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 132 LATIN AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 133 MIDDLE EAST: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2023-2030 (USD MILLION)
TABLE 134 GCC COUNTRIES: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 135 CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 136 NORTH AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 137 EUROPE: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 138 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 139 LATIN AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 140 MIDDLE EAST: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 141 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 142 CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 143 NORTH AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 144 EUROPE: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 145 ASIA PACIFIC: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 146 LATIN AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 147 MIDDLE EAST: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 148 GCC COUNTRIES: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 149 CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 150 NORTH AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 151 EUROPE: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 152 ASIA PACIFIC: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 153 LATIN AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 154 MIDDLE EAST: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 155 GCC COUNTRIES: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 156 CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 157 NORTH AMERICA: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 158 EUROPE: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 159 ASIA PACIFIC: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 160 LATIN AMERICA: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 161 MIDDLE EAST: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 162 GCC COUNTRIES: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 163 CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 164 NORTH AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 165 EUROPE: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 166 ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 167 LATIN AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 168 MIDDLE EAST: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 169 GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 170 CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2023-2030 (USD MILLION)
TABLE 171 NORTH AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 172 EUROPE: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 173 ASIA PACIFIC: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 174 LATIN AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 175 MIDDLE EAST: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2023-2030 (USD MILLION)
TABLE 176 GCC COUNTRIES: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 177 CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 178 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 179 EUROPE: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 180 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 181 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 182 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 183 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 184 CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 185 CELL CULTURE SERA MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 186 NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 187 EUROPE: CELL CULTURE SERA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 188 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 189 LATIN AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 190 MIDDLE EAST: CELL CULTURE SERA MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 191 GCC COUNTRIES: CELL CULTURE SERA MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 192 CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2023-2030 (USD MILLION)
TABLE 193 NORTH AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 194 EUROPE: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 195 ASIA PACIFIC: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 196 LATIN AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 197 MIDDLE EAST: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2023-2030 (USD MILLION)
TABLE 198 GCC COUNTRIES: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 199 CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2023-2030 (USD MILLION)
TABLE 200 NORTH AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 201 EUROPE: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 202 ASIA PACIFIC: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 203 LATIN AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 204 MIDDLE EAST: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2023-2030 (USD MILLION)
TABLE 205 GCC COUNTRIES: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 206 CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2023-2030 (USD MILLION)
TABLE 207 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 208 EUROPE: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 209 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 210 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 211 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2023-2030 (USD MILLION)
TABLE 212 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 213 CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 214 CELL CULTURE VESSELS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 215 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 216 EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 217 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 218 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 219 MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 220 GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 221 CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2023-2030 (USD MILLION)
TABLE 222 NORTH AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 223 EUROPE: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 224 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 225 LATIN AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 226 MIDDLE EAST: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY REGION, 2023-2030 (USD MILLION)
TABLE 227 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 228 CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2023-2030 (USD MILLION)
TABLE 229 NORTH AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 230 EUROPE: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 231 ASIA PACIFIC: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 232 LATIN AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 233 MIDDLE EAST: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2023-2030 (USD MILLION)
TABLE 234 GCC COUNTRIES: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 235 CELL CULTURE MARKET FOR FLASKS, BY REGION, 2023-2030 (USD MILLION)
TABLE 236 NORTH AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 237 EUROPE: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 238 ASIA PACIFIC: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 239 LATIN AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 240 MIDDLE EAST: CELL CULTURE MARKET FOR FLASKS, BY REGION, 2023-2030 (USD MILLION)
TABLE 241 GCC COUNTRIES: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 242 CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2023-2030 (USD MILLION)
TABLE 243 NORTH AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 244 EUROPE: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 245 ASIA PACIFIC: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 246 LATIN AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 247 MIDDLE EAST: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2023-2030 (USD MILLION)
TABLE 248 GCC COUNTRIES: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 249 CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2023-2030 (USD MILLION)
TABLE 250 NORTH AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 251 EUROPE: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 252 ASIA PACIFIC: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 253 LATIN AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 254 MIDDLE EAST: CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2023-2030 (USD MILLION)
TABLE 255 GCC COUNTRIES: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 256 CELL CULTURE ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 257 NORTH AMERICA: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 258 EUROPE: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 259 ASIA PACIFIC: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 260 LATIN AMERICA: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 261 MIDDLE EAST: CELL CULTURE ACCESSORIES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 262 GCC COUNTRIES: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 263 CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 264 CELL CULTURE EQUIPMENT MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 265 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 266 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 267 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 268 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 269 MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 270 GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 271 CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 272 CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 273 NORTH AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 274 EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 275 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 276 LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 277 MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 278 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 279 CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 280 NORTH AMERICA: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 281 EUROPE: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 282 ASIA PACIFIC: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 283 LATIN AMERICA: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 284 MIDDLE EAST: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 285 GCC COUNTRIES: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 286 COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS BY KEY PLAYERS
TABLE 287 CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 288 NORTH AMERICA: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 289 EUROPE: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 290 ASIA PACIFIC: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 291 LATIN AMERICA: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 292 MIDDLE EAST: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 293 GCC COUNTRIES: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 294 CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 295 CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 296 NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 297 EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 298 ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 299 LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 300 MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 301 GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 302 CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 303 NORTH AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 304 EUROPE: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 305 ASIA PACIFIC: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 306 LATIN AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 307 MIDDLE EAST: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 308 GCC COUNTRIES: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 309 CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
TABLE 310 NORTH AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 311 EUROPE: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 312 ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 313 LATIN AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 314 MIDDLE EAST: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
TABLE 315 GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 316 CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 317 CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 318 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 319 EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 320 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 321 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 322 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 323 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 324 FILTRATION SYSTEMS OFFERED BY KEY PLAYERS
TABLE 325 CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
TABLE 326 NORTH AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 327 EUROPE: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 328 ASIA PACIFIC: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 329 LATIN AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 330 MIDDLE EAST: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
TABLE 331 GCC COUNTRIES: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 332 CELL COUNTERS OFFERED BY KEY MARKET PLAYERS
TABLE 333 CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 334 NORTH AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 335 EUROPE: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 336 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 337 LATIN AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 338 MIDDLE EAST: CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 339 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 340 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS
TABLE 341 CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 342 NORTH AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 343 EUROPE: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 344 ASIA PACIFIC: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 345 LATIN AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 346 MIDDLE EAST: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY REGION, 2023-2030 (USD MILLION)
TABLE 347 GCC COUNTRIES: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 348 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS
TABLE 349 CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION, 2023-2030 (USD MILLION)
TABLE 350 NORTH AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 351 EUROPE: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 352 ASIA PACIFIC: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 353 LATIN AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 354 MIDDLE EAST: CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION, 2023-2030 (USD MILLION)
TABLE 355 GCC COUNTRIES: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 356 CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION, 2023-2030 (USD MILLION)
TABLE 357 NORTH AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 358 EUROPE: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 359 ASIA PACIFIC: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 360 LATIN AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 361 MIDDLE EAST: CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION, 2023-2030 (USD MILLION)
TABLE 362 GCC COUNTRIES: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 363 CELL CULTURE MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION)
TABLE 364 NORTH AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 365 EUROPE: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 366 ASIA PACIFIC: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 367 LATIN AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 368 MIDDLE EAST: CELL CULTURE MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION)
TABLE 369 GCC COUNTRIES: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 370 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS
TABLE 371 CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION, 2023-2030 (USD MILLION)
TABLE 372 NORTH AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 373 EUROPE: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 374 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 375 LATIN AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 376 MIDDLE EAST: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION, 2023-2030 (USD MILLION)
TABLE 377 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 378 OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS
TABLE 379 CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 380 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 381 EUROPE: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 382 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 383 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 384 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 385 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 386 CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 387 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 388 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 389 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 390 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 391 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 392 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 393 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 394 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 395 CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 396 NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 397 EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 398 ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 399 LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 400 MIDDLE EAST: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 401 GCC COUNTRIES: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 402 CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 403 NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 404 EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 405 ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 406 LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 407 MIDDLE EAST: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 408 GCC COUNTRIES: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 409 CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 410 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 411 EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 412 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 413 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 414 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2023-2030 (USD MILLION)
TABLE 415 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 416 CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 417 NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 418 EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 419 ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 420 LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTI CS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 421 MIDDLE EAST: CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 422 GCC COUNTRIES: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 423 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023-2030 (USD MILLION)
TABLE 424 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 425 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 426 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 427 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 428 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023-2030 (USD MILLION)
TABLE 429 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 430 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 431 CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2023-2030 (USD MILLION)
TABLE 432 NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 433 EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 434 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 435 LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 436 MIDDLE EAST: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2023-2030 (USD MILLION)
TABLE 437 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 438 CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 439 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 440 EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 441 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 442 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 443 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 444 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 445 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 446 NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 447 EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 448 ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 449 LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 450 MIDDLE EAST: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2023-2030 (USD MILLION)
TABLE 451 GCC COUNTRIES: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 452 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 453 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 454 EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 455 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 456 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 457 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 458 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 459 CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 460 RECENT DEVELOPMENTS IN PHARMA & BIOTECH SECTOR, 2021-2024
TABLE 461 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 462 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 463 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 464 ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 465 LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 466 MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 467 GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 468 CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 469 NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 470 EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 471 ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 472 LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 473 MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 474 GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 475 CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 476 NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 477 EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 478 ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 479 LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 480 MIDDLE EAST: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 481 GCC COUNTRIES: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 482 CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 483 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 484 EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 485 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 486 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 487 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 488 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 489 CELL CULTURE MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 490 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 491 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 492 NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 493 NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 494 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 495 NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 496 NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 497 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 498 NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 499 NORTH AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 500 NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 501 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 502 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 503 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 504 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 505 NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 506 INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2024-2024
TABLE 507 US: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 508 US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 509 US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 510 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 511 US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 512 US: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 513 US: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 514 US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 515 US: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 516 US: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 517 US: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 518 US: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 519 US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 520 US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 521 US: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 522 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 523 CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 524 CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 525 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 526 CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 527 CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 528 CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 529 CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 530 CANADA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 531 CANADA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 532 CANADA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 533 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 534 CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 535 CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 536 CANADA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 537 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 538 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 539 EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 540 EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 541 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 542 EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 543 EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 544 EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 545 EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 546 EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 547 EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 548 EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 549 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 550 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 551 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 552 EUROPE: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 553 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 554 GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 555 GERMANY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 556 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 557 GERMANY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 558 GERMANY: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 559 GERMANY: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 560 GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 561 GERMANY: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 562 GERMANY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 563 GERMANY: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 564 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 565 GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 566 GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 567 GERMANY: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 568 UK: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 569 UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 570 UK: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 571 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 572 UK: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 573 UK: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 574 UK: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 575 UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 576 UK: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 577 UK: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 578 UK: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 579 UK: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 580 UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 581 UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 582 UK: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 583 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 584 FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 585 FRANCE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 586 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 587 FRANCE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 588 FRANCE: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 589 FRANCE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 590 FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 591 FRANCE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 592 FRANCE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 593 FRANCE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 594 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 595 FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 596 FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 597 FRANCE: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 598 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 599 ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 600 ITALY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 601 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 602 ITALY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 603 ITALY: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 604 ITALY: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 605 ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 606 ITALY: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 607 ITALY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 608 ITALY: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 609 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 610 ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 611 ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 612 ITALY: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 613 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 614 SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 615 SPAIN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 616 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 617 SPAIN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 618 SPAIN: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 619 SPAIN: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 620 SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 621 SPAIN: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 622 SPAIN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 623 SPAIN: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 624 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 625 SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 626 SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 627 SPAIN: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 628 REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 629 REST OF EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 630 REST OF EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 631 REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 632 REST OF EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 633 REST OF EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 634 REST OF EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 635 REST OF EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 636 REST OF EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 637 REST OF EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 638 REST OF EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 639 REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 640 REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 641 REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 642 REST OF EUROPE: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 643 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 644 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 645 ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 646 ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 647 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 648 ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 649 ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 650 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 651 ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 652 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 653 ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 654 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 655 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 656 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 657 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 658 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 659 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 660 CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 661 CHINA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 662 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 663 CHINA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 664 CHINA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 665 CHINA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 666 CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 667 CHINA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 668 CHINA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 669 CHINA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 670 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 671 CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 672 CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 673 CHINA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 674 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 675 JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 676 JAPAN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 677 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 678 JAPAN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 679 JAPAN: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 680 JAPAN: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 681 JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 682 JAPAN: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 683 JAPAN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 684 JAPAN: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 685 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 686 JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 687 JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 688 JAPAN: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 689 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 690 INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 691 INDIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 692 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 693 INDIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 694 INDIA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 695 INDIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 696 INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 697 INDIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 698 INDIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 699 INDIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 700 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 701 INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 702 INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 703 INDIA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 704 SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 705 SOUTH KOREA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 706 SOUTH KOREA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 707 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 708 SOUTH KOREA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 709 SOUTH KOREA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 710 SOUTH KOREA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 711 SOUTH KOREA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 712 SOUTH KOREA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 713 SOUTH KOREA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 714 SOUTH KOREA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 715 SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 716 SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 717 SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 718 SOUTH KOREA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 719 AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 720 AUSTRALIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 721 AUSTRALIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 722 AUSTRALIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 723 AUSTRALIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 724 AUSTRALIA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 725 AUSTRALIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 726 AUSTRALIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 727 AUSTRALIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 728 AUSTRALIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 729 AUSTRALIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 730 AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 731 AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 732 AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 733 AUSTRALIA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 734 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 735 REST OF ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 736 REST OF ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 737 REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 738 REST OF ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 739 REST OF ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 740 REST OF ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 741 REST OF ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 742 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 743 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 744 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 745 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 746 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 747 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 748 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 749 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 750 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 751 LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 752 LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 753 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 754 LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 755 LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 756 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 757 LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 758 LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 759 LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 760 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 761 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 762 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 763 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 764 LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 765 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 766 BRAZIL: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 767 BRAZIL: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 768 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 769 BRAZIL: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 770 BRAZIL: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 771 BRAZIL: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 772 BRAZIL: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 773 BRAZIL: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 774 BRAZIL: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 775 BRAZIL: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 776 BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 777 BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 778 BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 779 BRAZIL: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 780 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 781 MEXICO: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 782 MEXICO: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 783 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 784 MEXICO: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 785 MEXICO: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 786 MEXICO: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 787 MEXICO: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 788 MEXICO: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 789 MEXICO: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 790 MEXICO: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 791 MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 792 MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 793 MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 794 MEXICO: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 795 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 796 REST OF LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 797 REST OF LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 798 REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 799 REST OF LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 800 REST OF LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 801 REST OF LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 802 REST OF LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 803 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 804 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 805 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 806 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 807 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 808 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 809 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 810 MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 811 MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 812 MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 813 MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 814 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 815 MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 816 MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 817 MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 818 MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 819 MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 820 MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 821 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 822 MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 823 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 824 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 825 MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 826 GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 827 GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 828 GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 829 GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 830 GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 831 GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 832 GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 833 GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 834 GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 835 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 836 GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 837 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 838 GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 839 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 840 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 841 GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 842 SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 843 SAUDI ARABIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 844 SAUDI ARABIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 845 SAUDI ARABIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 846 SAUDI ARABIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 847 SAUDI ARABIA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 848 SAUDI ARABIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 849 SAUDI ARABIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 850 SAUDI ARABIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 851 SAUDI ARABIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 852 SAUDI ARABIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 853 SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 854 SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 855 SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 856 SAUDI ARABIA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 857 UAE: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 858 UAE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 859 UAE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 860 UAE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 861 UAE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 862 UAE: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 863 UAE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 864 UAE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 865 UAE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 866 UAE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 867 UAE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 868 UAE: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 869 UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 870 UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 871 UAE: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 872 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 873 REST OF GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 874 REST OF GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 875 REST OF GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 876 REST OF GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 877 REST OF GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 878 REST OF GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 879 REST OF GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 880 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 881 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 882 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 883 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 884 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 885 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 886 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 887 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 888 REST OF MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 889 REST OF MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 890 REST OF MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 891 REST OF MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 892 REST OF MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 893 REST OF MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 894 REST OF MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 895 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 896 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 897 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 898 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 899 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 900 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 901 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 902 AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
TABLE 903 AFRICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 904 AFRICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 905 AFRICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 906 AFRICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 907 AFRICA: CELL CULTURE SERA MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 908 AFRICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 909 AFRICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 910 AFRICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023-2030 (USD MILLION)
TABLE 911 AFRICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 912 AFRICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023-2030 (USD MILLION)
TABLE 913 AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
TABLE 914 AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023-2030 (USD MILLION)
TABLE 915 AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023-2030 (USD MILLION)
TABLE 916 AFRICA: CELL CULTURE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 917 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, JANUARY 2022-JUNE 2025
TABLE 918 CELL CULTURE MARKET: DEGREE OF COMPETITION
TABLE 919 CELL CULTURE MARKET: REGION FOOTPRINT
TABLE 920 CELL CULTURE MARKET: PRODUCT FOOTPRINT
TABLE 921 CELL CULTURE MARKET: APPLICATION FOOTPRINT
TABLE 922 CELL CULTURE MARKET: END-USER FOOTPRINT
TABLE 923 CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 924 CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 925 CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 926 CELL CULTURE MARKET: DEALS, JANUARY 2021-JUNE 2025
TABLE 927 CELL CULTURE MARKET: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 928 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 929 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 930 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 931 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-JUNE 2025
TABLE 932 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 933 DANAHER: COMPANY OVERVIEW
TABLE 934 DANAHER: PRODUCTS OFFERED
TABLE 935 DANAHER: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 936 DANAHER: DEALS, JANUARY 2021-JUNE 2025
TABLE 937 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 938 DANAHER: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2025
TABLE 939 MERCK KGAA: COMPANY OVERVIEW
TABLE 940 MERCK KGAA: PRODUCTS OFFERED
TABLE 941 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 942 MERCK KGAA: DEALS, JANUARY 2021-JUNE 2025
TABLE 943 MERCK KGAA: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 944 SARTORIUS AG: COMPANY OVERVIEW
TABLE 945 SARTORIUS AG: PRODUCTS OFFERED
TABLE 946 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 947 SARTORIUS AG.: DEALS, JANUARY 2021-JUNE 2025
TABLE 948 SARTORIUS AG: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 949 CORNING INCORPORATED: COMPANY OVERVIEW
TABLE 950 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 951 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 952 CORNING INCORPORATED: DEALS, JANUARY 2021-JUNE 2025
TABLE 953 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 954 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 955 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 956 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021-JUNE 2025
TABLE 957 FUJIFILM HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 958 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2025
TABLE 959 BD: COMPANY OVERVIEW
TABLE 960 BD: PRODUCTS OFFERED
TABLE 961 BD: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 962 BD: DEALS, JANUARY 2021-JUNE 2025
TABLE 963 EPPENDORF SE: COMPANY OVERVIEW
TABLE 964 EPPENDORF SE: PRODUCTS OFFERED
TABLE 965 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 966 EPPENDORF SE: DEALS, JANUARY 2021-JUNE 2025
TABLE 967 EPPENDORF SE: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 968 LONZA: COMPANY OVERVIEW
TABLE 969 LONZA: PRODUCTS OFFERED
TABLE 970 LONZA: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 971 LONZA: DEALS, JANUARY 2021-JUNE 2025
TABLE 972 GETINGE: COMPANY OVERVIEW
TABLE 973 GETINGE: PRODUCTS OFFERED
TABLE 974 GETINGE: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 975 GETINGE: DEALS, JANUARY 2021-JUNE 2025
TABLE 976 GETINGE: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 977 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 978 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 979 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 980 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-JUNE 2025
TABLE 981 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 982 HIMEDIA LABORATORIES: COMPANY OVERVIEW
TABLE 983 HIMEDIA LABORATORIES: PRODUCTS OFFERED
TABLE 984 BIO-TECHNE: COMPANY OVERVIEW
TABLE 985 BIO-TECHNE: PRODUCTS OFFERED
TABLE 986 BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2025
TABLE 987 BIO-TECHNE: DEALS, JANUARY 2021-JUNE 2025
TABLE 988 BIO-TECHNE: EXPANSIONS, JANUARY 2021-JUNE 2025
TABLE 989 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 990 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 991 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW
TABLE 992 CAISSON LABS: COMPANY OVERVIEW
TABLE 993 PROMOCELL GMBH: COMPANY OVERVIEW
TABLE 994 INVIVOGEN: COMPANY OVERVIEW
TABLE 995 PAN-BIOTECH: COMPANY OVERVIEW
TABLE 996 CELLEXUS: COMPANY OVERVIEW
TABLE 997 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
TABLE 998 ADOLF KUHNER AG: COMPANY OVERVIEW
TABLE 999 ADVANCION CORPORATION: COMPANY OVERVIEW
TABLE 1000 BIOSPHERIX LLC: COMPANY OVERVIEW

List of Figures

FIGURE 1 CELL CULTURE MARKET SEGMENTATION
FIGURE 2 REGIONAL SCOPE
FIGURE 3 CELL CULTURE MARKET: RESEARCH DESIGN
FIGURE 4 CELL CULTURE MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 5 CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
FIGURE 7 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2024
FIGURE 8 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 9 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 10 CELL CULTURE MARKET: CAGR PROJECTIONS (2025-2030)
FIGURE 11 DATA TRIANGULATION METHODOLOGY
FIGURE 12 CELL CULTURE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 13 CELL CULTURE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 14 CELL CULTURE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF CELL CULTURE MARKET
FIGURE 16 GROWING POPULARITY OF MONOCLONAL ANTIBODIES AND BIOSIMILARS TO DRIVE MARKET
FIGURE 17 CONSUMABLES SEGMENT AND US LED NORTH AMERICAN MARKET IN 2024
FIGURE 18 BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED END-USER MARKET IN 2024
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 21 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU, 2012-2024
FIGURE 23 NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED, 2015-2024
FIGURE 24 CLINICAL TRIAL OVERVIEW OF TISSUE-ENGINEERED PRODUCTS, 2019-2023
FIGURE 25 GLOBAL HIV EPIDEMIC, 2023
FIGURE 26 NEW REVENUE POCKETS FOR PLAYERS IN CELL CULTURE MARKET
FIGURE 27 AVERAGE SELLING PRICE TREND OF CELL-BASED ASSAY PRODUCTS, 2022-2024
FIGURE 28 CELL CULTURE MARKET: VALUE CHAIN ANALYSIS
FIGURE 29 CELL CULTURE MARKET: ECOSYSTEM ANALYSIS
FIGURE 30 CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO, 2020-2024
FIGURE 31 CELL CULTURE MARKET: PATENT ANALYSIS, 2014-2024
FIGURE 32 CELL CULTURE MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL CULTURE PRODUCTS
FIGURE 34 KEY BUYING CRITERIA, BY END USER
FIGURE 35 AI USE CASES
FIGURE 36 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
FIGURE 37 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2020-2024 (USD BILLION)
FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2024
FIGURE 40 EV/EBITDA OF KEY VENDORS
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42 CELL CULTURE MARKET: BRAND/PRODUCT COMPARISON
FIGURE 43 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 44 CELL CULTURE MARKET: COMPANY FOOTPRINT
FIGURE 45 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 47 DANAHER: COMPANY SNAPSHOT (2024)
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2024)
FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2024)
FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2024)
FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 52 BD: COMPANY SNAPSHOT (2024)
FIGURE 53 EPPENDORF SE: COMPANY SNAPSHOT (2024)
FIGURE 54 LONZA: COMPANY SNAPSHOT (2024)
FIGURE 55 GETINGE: COMPANY SNAPSHOT (2024)
FIGURE 56 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 57 BIO-TECHNE: COMPANY SNAPSHOT (2024)